Parallax Volatility Advisers Discloses New Stakes in CenterPoint, Lemonade, and Other Major Equities

Deutsche Bank AG opened a new CenterPoint Energy position in the second quarter, valued at about $770.9 million.
BlackRock Inc. bought a new Lemonade stake in the second quarter, valued at about $393.4 million.
BlackRock Inc. acquired a new position in Newell Brands in the second quarter, valued at about $436.1 million.
Empowered Funds LLC increased its Biogen stake by 64.9% in the first quarter, while Cerity Partners LLC lifted its Biogen holdings by 15.3% in the second quarter.
Parallax Volatility Advisers L.P. acquired 14,412 American Electric Power shares in the second quarter, worth about $1.97 million.
Parallax Volatility Advisers L.P. made a series of new stock purchases in the second quarter, signaling confidence in a diverse set of U.S. companies. The hedge fund bought 21,106 shares of CenterPoint Energy worth roughly $930,000, according to Watchlist News, while also establishing positions in insurance tech, consumer goods, and pharmaceuticals. The moves reflect broader institutional appetite for equities across energy, retail, and healthcare sectors.
Parallax's investment wave coincided with similar moves by heavyweight firms like Deutsche Bank and BlackRock. Watchlist News noted that Deutsche Bank opened a $770.9 million CenterPoint stake while BlackRock deployed hundreds of millions into Lemonade and Newell Brands. The synchronized buying suggests investors see value in these overlooked names.
CenterPoint Energy drew big-money interest in the second quarter from multiple institutional players. Parallax acquired 21,106 shares for $930,000, according to Watchlist News, while German banking giant Deutsche Bank made a much larger entry with a $770.9 million position. The utility's appeal likely stems from stable dividend income and infrastructure exposure as energy demand grows.
Parallax also wagered on consumer-facing companies and emerging tech plays. The firm bought 25,171 Lemonade shares worth $1.64 million and 200,000 Newell Brands shares for $1.23 million during Q2, per Watchlist News. BlackRock followed with even bigger allocations—$393.4 million in Lemonade and $436.1 million in Newell Brands—suggesting institutional belief that both sectors deserve portfolio space.
Healthcare stocks also landed on Parallax's radar. The firm bought 2,291 Biogen shares worth around $495,000 in Q2, according to Watchlist News. Biogen had already caught attention from other funds—Empowered Funds boosted its stake by 64.9% in Q1 while Cerity Partners lifted holdings by 15.3% in Q2. The repeated buying suggests optimism about Biogen's pipeline or valuation.
Beyond CenterPoint, Parallax also grabbed exposure to another major utility. The fund acquired 14,412 American Electric Power shares worth $1.97 million in Q2, Watchlist News reported. The dual utility bets suggest Parallax sees attractive risk-reward in regulated power companies as infrastructure spending picks up and rates stabilize.
Publishers
14
Articles
7
Reach
21